Titre:
  • Cost-effectiveness of oral ibandronate versus IV zoledronic acid or IV pamidronate for bone metastases in patients receiving oral hormonal therapy for breast cancer in the United Kingdom
Auteur:De Cock, Erwin; Hutton, John; Canney, Peter; Body, Jean-Jacques; Barrett-Lee, Peter; Neary, Maureen; Lewis, Gavin
Informations sur la publication:Clinical therapeutics, 27, 8, page (1295-1310)
Statut de publication:Publié, 2005-08
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Bisphosphonate
Bone metastases
Cost-effectiveness
Ibandronate
Oral
Skeletal-related events
Zoledronic acid
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0149-2918
info:doi/10.1016/j.clinthera.2005.08.006
info:pii/S0149291805001542
info:scp/25844513080
info:pmid/16199254